期刊文献+

下调Six1基因表达对胃癌细胞生物学特性及B7-H1表达的影响 被引量:1

下载PDF
导出
摘要 目的探讨抑制胃癌细胞Six1表达对癌细胞增殖侵袭及B7-H1表达的影响及机制。方法以人正常胃黏膜上皮细胞GES-1为对照细胞,Western印迹检测胃癌MKN45、BGC823和AGS细胞Six1的蛋白表达;参照LipofectamineTM2000转染说明将非特异性siRNA(NC组)和Six1特异性的siRNA(si-Six1组)转染BGC823细胞,并设置空白对照组,转染48 h,通过MTT及Transwell小室分别检测各组细胞活力及侵袭能力;Western印迹检测Six1、B7-H1及JAK2/STAT3信号通路磷酸化的JAK2、STAT3及下游分子细胞周期蛋白(cyclin)D1和基质金属蛋白酶(MMP)-2的蛋白表达。结果胃癌MKN45、BGC823和AGS细胞Six1的表达均显著高于在GES-1细胞表达(P<0.05);转染si-Six1的BGC823细胞Six1的蛋白表达显著低于空白对照组(P<0.05);与NC组比较,si-Six1组细胞活力及侵袭能力均显著降低,B7-H1、p-JAK2、p-STAT3、cyclinD1和MMP-2的蛋白表达均显著降低(P<0.05)。结论下调胃癌细胞Six1表达可降低癌细胞活力及侵袭能力,降低B7-H1表达,机制可能是抑制JAK2/STAT3信号通路。
出处 《中国老年学杂志》 CAS 北大核心 2018年第8期1919-1922,共4页 Chinese Journal of Gerontology
基金 安徽省自然科学基金项目(1308085MA13)
  • 相关文献

参考文献3

二级参考文献8

  • 1Hua Dong, Sun Jing, Mao Yong, Wu Yuyu, Zhou Huan, Zhu Ming. Abnormal expression of B7-H1 in the tumor microenvironment and the promotion of the regulatory T cell expansion. Journal of Soochow University, Medical Science) 2011; 31(3): 444-7.
  • 2Chen J, Li GS, Meng 14, Fan YC, Song YH, Wang SR. Upregula- tion of B7-H 1 expression is associated with macrophage infiltra- tion in hepatocellular carcinomas. Cancer lmmunol lmmunother 2012; 6l(l): 101-8.
  • 3Bloch O, Crane CA, Kaur R. Gliomas promote immunosuppression through induction of B7-HI expression in tumor-associated mac- rophages. Clin Cancer Res 2013; 19(12): 3165-75.
  • 4Dong HD, Chen LP. B7-H1 pathway and its role in the evasion of tumor immunity. Mol Med 2003; 81(5): 281-7.
  • 5Kuang DM, Zhao QY, Peng C, Xu J, Zhang JP, Wu CY. Activated monocytes in peritumoral stroma of hepatoce[lular carcinoma foster immune privilege and disease progression through PD-LI. Exp Med 2009; 206(6): 1327-37.
  • 6Marzec M, Zhang Q, Goradia A, Raghunath PN, Liu XB, Paessler M. Oncogenie kinase NPM/ALK induces through STAT3 expre- ssion of immunosuppressive protein CD274 (PD-LI, B7-H1). Proe Natl Acad Sei USA 2008; 105(52): 20852-7.
  • 7Chen YW, Zhang JB, Guo GN, Ruan ZH, Jiang M, Wu SX. In- duced B7-H1 expression on human renal tubular epithelial cells by the sublytic terminal complement complex C5b-9. Mol lmmu- nol 2009; 46(3): 375-83.
  • 8WOlfle S J, Strebovsky J, Bartz 14, SaOhr A, Arnold C, Kaiser C. PD-L1 expression on tolerogenic APCs is controlled by STAT-3. Eur J Immunol 2011; 41(2): 413-24.

共引文献15

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部